TY  - GEN
AU  - Pérez-Belmonte, Luis M
AU  - Torres-Peña, José David
AU  - López-Carmona, María D
AU  - Ayala-Gutiérrez, M Mar
AU  - Fuentes-Jiménez, Francisco
AU  - Huerta, Lucía Jorge
AU  - Muñoz, Jaime Alonso
AU  - Rubio-Rivas, Manuel
AU  - Madrazo, Manel
AU  - Garcia, Marcos Guzmán
AU  - Montes, Beatriz Vicente
AU  - Sola, Joaquim Fernández
AU  - Ena, Javier
AU  - Ferrer, Ruth Gonzalez
AU  - Pérez, Carmen Mella
AU  - Ripper, Carlos Jorge
AU  - Lecumberri, Jose Javier Napal
AU  - Acedo, Iris El Attar
AU  - Canteli, Susana Plaza
AU  - Cosío, Sara Fuente
AU  - Martínez, Francisco Amorós
AU  - Rodríguez, Begoña Cortés
AU  - Pérez-Martínez, Pablo
AU  - Ramos-Rincón, José Manuel
AU  - Gómez-Huelgas, Ricardo
AU  - SEMI-COVID-19 Network
PY  - 2020
DO  - 10.1186/s12916-020-01832-2
UR  - http://hdl.handle.net/20.500.12105/18152
AB  - Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital death and each routine at-home glucose-lowering drug both individually and in combination...
LA  - eng
KW  - Coronavirus disease 2019
KW  - Glucose-lowering drug
KW  - Type 2 diabetes mellitus
KW  - Aged
TI  - Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study.
TY  - research article
ER  -